HIMS241011C10000
- 7.15
- +0.15+2.14%
Hims & Hers Health Newsroom
Trending Stocks This Week as Strong Jobs Report Underscore Resilience of U.S. Economy
Weight-Loss Drugs Are Everywhere. How the GLP-1 Copycats Took Over. -- Barron's
Hims & Hers Health Set to Join S&P SmallCap 600
Express News | S&P Dow Jones Indices: Hims & Hers Health to Replace Vector Group Ltd in S&P Smallcap 600 Effective Prior to Market Open on Oct 9
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
Eli Lilly's Mounjaro, Zepbound Removed From FDA's Shortage List
US regulators said eli lilly and co's weight loss miracle drug is no longer in short supply, causing "平替" manufacturer Hims & Hers to drop nearly 10%.
FDA stated that eli lilly and co's two exenatide-containing GLP-1 injection Zepbound and Mounjaro have been in short supply since 2022 due to increased demand, but the shortage issue is now resolved. Industry organizations say that FDA's determination equals to pharmacies stopping the allocation and distribution of generic versions of the two drugs.
Hims & Hers Health Stock Tanks After FDA Says Competitor Eli Lilly's Weight-loss Drug Shortage Is Over
Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $20
Hims & Hers Health Options Spot-On: On October 3rd, 87,769 Contracts Were Traded, With 241.14K Open Interest
On October 3rd ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 87,769 options for the day, of which put options accounted for 39.29% of the total
Hims & Hers Health(HIMS.US) 10% Shareholder Sells US$6.06 Million in Common Stock
$Hims & Hers Health(HIMS.US)$ 10% Shareholder Dudum Andrew sold 333.33K shares of common stock on Oct 1, 2024 at an average price of $18.1937 for a total value of $6.06 million.Source: Announcement
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away -- Analysis
Top Midday Stories: Levi Strauss Shares Fall After Sales Miss, Strategic Review of Dockers Brand Announcement; Tesla's Model 3 Standard Range Variant Unavailable for Order in US
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
Sector Update: Health Care Stocks Steady Premarket Thursday
Sector Update: Health Care
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Top Premarket Decliners
Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List